Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
25,125
archived clinical trials in
Diabetes

Evaluation of the Bioavailability of Pramlintide
Status: Enrolling
Updated:  9/22/2015
Orlando Clinical Research Center
mi
from
Orlando, FL
Evaluation of the Bioavailability of Pramlintide
Status: Enrolling
Updated: 9/22/2015
Orlando Clinical Research Center
mi
from
Orlando, FL
Click here to add this to my saved trials
Evaluation of the Bioavailability of Pramlintide
Status: Enrolling
Updated:  9/22/2015
New Orleans Center for Clinical Research
mi
from
New Orleans, LA
Evaluation of the Bioavailability of Pramlintide
Status: Enrolling
Updated: 9/22/2015
New Orleans Center for Clinical Research
mi
from
New Orleans, LA
Click here to add this to my saved trials
Evaluation of the Bioavailability of Pramlintide
Status: Enrolling
Updated:  9/22/2015
DaVita Clinical Research
mi
from
Minneapolis, MN
Evaluation of the Bioavailability of Pramlintide
Status: Enrolling
Updated: 9/22/2015
DaVita Clinical Research
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Evaluation of the Bioavailability of Pramlintide
Status: Enrolling
Updated:  9/22/2015
CEDRA Clinical Research, LLC
mi
from
Austin, TX
Evaluation of the Bioavailability of Pramlintide
Status: Enrolling
Updated: 9/22/2015
CEDRA Clinical Research, LLC
mi
from
Austin, TX
Click here to add this to my saved trials
Study of the Long-Term Safety of Pramlintide in Subjects With Type 1 Diabetes Mellitus
A Multicenter, Open-Label, Extension Study of the Long-Term Safety of Pramlintide in Subjects With Type 1 Diabetes Mellitus Completing Protocol 137-150
Status: Enrolling
Updated:  9/22/2015
Clinical Research Facility
mi
from
Tempe, AZ
Study of the Long-Term Safety of Pramlintide in Subjects With Type 1 Diabetes Mellitus
A Multicenter, Open-Label, Extension Study of the Long-Term Safety of Pramlintide in Subjects With Type 1 Diabetes Mellitus Completing Protocol 137-150
Status: Enrolling
Updated: 9/22/2015
Clinical Research Facility
mi
from
Tempe, AZ
Click here to add this to my saved trials
Study of the Long-Term Safety of Pramlintide in Subjects With Type 1 Diabetes Mellitus
A Multicenter, Open-Label, Extension Study of the Long-Term Safety of Pramlintide in Subjects With Type 1 Diabetes Mellitus Completing Protocol 137-150
Status: Enrolling
Updated:  9/22/2015
Clinical Research Facility
mi
from
Concord, CA
Study of the Long-Term Safety of Pramlintide in Subjects With Type 1 Diabetes Mellitus
A Multicenter, Open-Label, Extension Study of the Long-Term Safety of Pramlintide in Subjects With Type 1 Diabetes Mellitus Completing Protocol 137-150
Status: Enrolling
Updated: 9/22/2015
Clinical Research Facility
mi
from
Concord, CA
Click here to add this to my saved trials
Study of the Long-Term Safety of Pramlintide in Subjects With Type 1 Diabetes Mellitus
A Multicenter, Open-Label, Extension Study of the Long-Term Safety of Pramlintide in Subjects With Type 1 Diabetes Mellitus Completing Protocol 137-150
Status: Enrolling
Updated:  9/22/2015
Clinical Research Facility
mi
from
Fresno, CA
Study of the Long-Term Safety of Pramlintide in Subjects With Type 1 Diabetes Mellitus
A Multicenter, Open-Label, Extension Study of the Long-Term Safety of Pramlintide in Subjects With Type 1 Diabetes Mellitus Completing Protocol 137-150
Status: Enrolling
Updated: 9/22/2015
Clinical Research Facility
mi
from
Fresno, CA
Click here to add this to my saved trials
Study of the Long-Term Safety of Pramlintide in Subjects With Type 1 Diabetes Mellitus
A Multicenter, Open-Label, Extension Study of the Long-Term Safety of Pramlintide in Subjects With Type 1 Diabetes Mellitus Completing Protocol 137-150
Status: Enrolling
Updated:  9/22/2015
Clinical Research Facility
mi
from
San Diego, CA
Study of the Long-Term Safety of Pramlintide in Subjects With Type 1 Diabetes Mellitus
A Multicenter, Open-Label, Extension Study of the Long-Term Safety of Pramlintide in Subjects With Type 1 Diabetes Mellitus Completing Protocol 137-150
Status: Enrolling
Updated: 9/22/2015
Clinical Research Facility
mi
from
San Diego, CA
Click here to add this to my saved trials
Study of the Long-Term Safety of Pramlintide in Subjects With Type 1 Diabetes Mellitus
A Multicenter, Open-Label, Extension Study of the Long-Term Safety of Pramlintide in Subjects With Type 1 Diabetes Mellitus Completing Protocol 137-150
Status: Enrolling
Updated:  9/22/2015
Clinical Research Facility
mi
from
San Mateo, CA
Study of the Long-Term Safety of Pramlintide in Subjects With Type 1 Diabetes Mellitus
A Multicenter, Open-Label, Extension Study of the Long-Term Safety of Pramlintide in Subjects With Type 1 Diabetes Mellitus Completing Protocol 137-150
Status: Enrolling
Updated: 9/22/2015
Clinical Research Facility
mi
from
San Mateo, CA
Click here to add this to my saved trials
Study of the Long-Term Safety of Pramlintide in Subjects With Type 1 Diabetes Mellitus
A Multicenter, Open-Label, Extension Study of the Long-Term Safety of Pramlintide in Subjects With Type 1 Diabetes Mellitus Completing Protocol 137-150
Status: Enrolling
Updated:  9/22/2015
Clinical Research Facility
mi
from
Santa Barbara, CA
Study of the Long-Term Safety of Pramlintide in Subjects With Type 1 Diabetes Mellitus
A Multicenter, Open-Label, Extension Study of the Long-Term Safety of Pramlintide in Subjects With Type 1 Diabetes Mellitus Completing Protocol 137-150
Status: Enrolling
Updated: 9/22/2015
Clinical Research Facility
mi
from
Santa Barbara, CA
Click here to add this to my saved trials
Study of the Long-Term Safety of Pramlintide in Subjects With Type 1 Diabetes Mellitus
A Multicenter, Open-Label, Extension Study of the Long-Term Safety of Pramlintide in Subjects With Type 1 Diabetes Mellitus Completing Protocol 137-150
Status: Enrolling
Updated:  9/22/2015
Clinical Research Facility
mi
from
Walnut Creek, CA
Study of the Long-Term Safety of Pramlintide in Subjects With Type 1 Diabetes Mellitus
A Multicenter, Open-Label, Extension Study of the Long-Term Safety of Pramlintide in Subjects With Type 1 Diabetes Mellitus Completing Protocol 137-150
Status: Enrolling
Updated: 9/22/2015
Clinical Research Facility
mi
from
Walnut Creek, CA
Click here to add this to my saved trials
Study of the Long-Term Safety of Pramlintide in Subjects With Type 1 Diabetes Mellitus
A Multicenter, Open-Label, Extension Study of the Long-Term Safety of Pramlintide in Subjects With Type 1 Diabetes Mellitus Completing Protocol 137-150
Status: Enrolling
Updated:  9/22/2015
Clinical Research Facility
mi
from
Aventura, FL
Study of the Long-Term Safety of Pramlintide in Subjects With Type 1 Diabetes Mellitus
A Multicenter, Open-Label, Extension Study of the Long-Term Safety of Pramlintide in Subjects With Type 1 Diabetes Mellitus Completing Protocol 137-150
Status: Enrolling
Updated: 9/22/2015
Clinical Research Facility
mi
from
Aventura, FL
Click here to add this to my saved trials
Study of the Long-Term Safety of Pramlintide in Subjects With Type 1 Diabetes Mellitus
A Multicenter, Open-Label, Extension Study of the Long-Term Safety of Pramlintide in Subjects With Type 1 Diabetes Mellitus Completing Protocol 137-150
Status: Enrolling
Updated:  9/22/2015
Clinical Research Facility
mi
from
Fort Myers, FL
Study of the Long-Term Safety of Pramlintide in Subjects With Type 1 Diabetes Mellitus
A Multicenter, Open-Label, Extension Study of the Long-Term Safety of Pramlintide in Subjects With Type 1 Diabetes Mellitus Completing Protocol 137-150
Status: Enrolling
Updated: 9/22/2015
Clinical Research Facility
mi
from
Fort Myers, FL
Click here to add this to my saved trials
Study of the Long-Term Safety of Pramlintide in Subjects With Type 1 Diabetes Mellitus
A Multicenter, Open-Label, Extension Study of the Long-Term Safety of Pramlintide in Subjects With Type 1 Diabetes Mellitus Completing Protocol 137-150
Status: Enrolling
Updated:  9/22/2015
Clinical Research Facility
mi
from
New Port Richey, FL
Study of the Long-Term Safety of Pramlintide in Subjects With Type 1 Diabetes Mellitus
A Multicenter, Open-Label, Extension Study of the Long-Term Safety of Pramlintide in Subjects With Type 1 Diabetes Mellitus Completing Protocol 137-150
Status: Enrolling
Updated: 9/22/2015
Clinical Research Facility
mi
from
New Port Richey, FL
Click here to add this to my saved trials
Study of the Long-Term Safety of Pramlintide in Subjects With Type 1 Diabetes Mellitus
A Multicenter, Open-Label, Extension Study of the Long-Term Safety of Pramlintide in Subjects With Type 1 Diabetes Mellitus Completing Protocol 137-150
Status: Enrolling
Updated:  9/22/2015
Clinical Research Facility
mi
from
Tallahassee, FL
Study of the Long-Term Safety of Pramlintide in Subjects With Type 1 Diabetes Mellitus
A Multicenter, Open-Label, Extension Study of the Long-Term Safety of Pramlintide in Subjects With Type 1 Diabetes Mellitus Completing Protocol 137-150
Status: Enrolling
Updated: 9/22/2015
Clinical Research Facility
mi
from
Tallahassee, FL
Click here to add this to my saved trials
Study of the Long-Term Safety of Pramlintide in Subjects With Type 1 Diabetes Mellitus
A Multicenter, Open-Label, Extension Study of the Long-Term Safety of Pramlintide in Subjects With Type 1 Diabetes Mellitus Completing Protocol 137-150
Status: Enrolling
Updated:  9/22/2015
Clinical Research Facility
mi
from
Atlanta, GA
Study of the Long-Term Safety of Pramlintide in Subjects With Type 1 Diabetes Mellitus
A Multicenter, Open-Label, Extension Study of the Long-Term Safety of Pramlintide in Subjects With Type 1 Diabetes Mellitus Completing Protocol 137-150
Status: Enrolling
Updated: 9/22/2015
Clinical Research Facility
mi
from
Atlanta, GA
Click here to add this to my saved trials
Study of the Long-Term Safety of Pramlintide in Subjects With Type 1 Diabetes Mellitus
A Multicenter, Open-Label, Extension Study of the Long-Term Safety of Pramlintide in Subjects With Type 1 Diabetes Mellitus Completing Protocol 137-150
Status: Enrolling
Updated:  9/22/2015
Clinical Research Facility
mi
from
Indianapolis, IN
Study of the Long-Term Safety of Pramlintide in Subjects With Type 1 Diabetes Mellitus
A Multicenter, Open-Label, Extension Study of the Long-Term Safety of Pramlintide in Subjects With Type 1 Diabetes Mellitus Completing Protocol 137-150
Status: Enrolling
Updated: 9/22/2015
Clinical Research Facility
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Study of the Long-Term Safety of Pramlintide in Subjects With Type 1 Diabetes Mellitus
A Multicenter, Open-Label, Extension Study of the Long-Term Safety of Pramlintide in Subjects With Type 1 Diabetes Mellitus Completing Protocol 137-150
Status: Enrolling
Updated:  9/22/2015
Clinical Research Facility
mi
from
Detroit, MI
Study of the Long-Term Safety of Pramlintide in Subjects With Type 1 Diabetes Mellitus
A Multicenter, Open-Label, Extension Study of the Long-Term Safety of Pramlintide in Subjects With Type 1 Diabetes Mellitus Completing Protocol 137-150
Status: Enrolling
Updated: 9/22/2015
Clinical Research Facility
mi
from
Detroit, MI
Click here to add this to my saved trials
Study of the Long-Term Safety of Pramlintide in Subjects With Type 1 Diabetes Mellitus
A Multicenter, Open-Label, Extension Study of the Long-Term Safety of Pramlintide in Subjects With Type 1 Diabetes Mellitus Completing Protocol 137-150
Status: Enrolling
Updated:  9/22/2015
Clinical Research Facility
mi
from
Grand Rapids, MI
Study of the Long-Term Safety of Pramlintide in Subjects With Type 1 Diabetes Mellitus
A Multicenter, Open-Label, Extension Study of the Long-Term Safety of Pramlintide in Subjects With Type 1 Diabetes Mellitus Completing Protocol 137-150
Status: Enrolling
Updated: 9/22/2015
Clinical Research Facility
mi
from
Grand Rapids, MI
Click here to add this to my saved trials
Study of the Long-Term Safety of Pramlintide in Subjects With Type 1 Diabetes Mellitus
A Multicenter, Open-Label, Extension Study of the Long-Term Safety of Pramlintide in Subjects With Type 1 Diabetes Mellitus Completing Protocol 137-150
Status: Enrolling
Updated:  9/22/2015
Clinical Research Facility
mi
from
St. Peters, MO
Study of the Long-Term Safety of Pramlintide in Subjects With Type 1 Diabetes Mellitus
A Multicenter, Open-Label, Extension Study of the Long-Term Safety of Pramlintide in Subjects With Type 1 Diabetes Mellitus Completing Protocol 137-150
Status: Enrolling
Updated: 9/22/2015
Clinical Research Facility
mi
from
St. Peters, MO
Click here to add this to my saved trials
Study of the Long-Term Safety of Pramlintide in Subjects With Type 1 Diabetes Mellitus
A Multicenter, Open-Label, Extension Study of the Long-Term Safety of Pramlintide in Subjects With Type 1 Diabetes Mellitus Completing Protocol 137-150
Status: Enrolling
Updated:  9/22/2015
Clinical Research Facility
mi
from
Butte, MT
Study of the Long-Term Safety of Pramlintide in Subjects With Type 1 Diabetes Mellitus
A Multicenter, Open-Label, Extension Study of the Long-Term Safety of Pramlintide in Subjects With Type 1 Diabetes Mellitus Completing Protocol 137-150
Status: Enrolling
Updated: 9/22/2015
Clinical Research Facility
mi
from
Butte, MT
Click here to add this to my saved trials
Study of the Long-Term Safety of Pramlintide in Subjects With Type 1 Diabetes Mellitus
A Multicenter, Open-Label, Extension Study of the Long-Term Safety of Pramlintide in Subjects With Type 1 Diabetes Mellitus Completing Protocol 137-150
Status: Enrolling
Updated:  9/22/2015
Clinical Research Facility
mi
from
Durham, NC
Study of the Long-Term Safety of Pramlintide in Subjects With Type 1 Diabetes Mellitus
A Multicenter, Open-Label, Extension Study of the Long-Term Safety of Pramlintide in Subjects With Type 1 Diabetes Mellitus Completing Protocol 137-150
Status: Enrolling
Updated: 9/22/2015
Clinical Research Facility
mi
from
Durham, NC
Click here to add this to my saved trials
Study of the Long-Term Safety of Pramlintide in Subjects With Type 1 Diabetes Mellitus
A Multicenter, Open-Label, Extension Study of the Long-Term Safety of Pramlintide in Subjects With Type 1 Diabetes Mellitus Completing Protocol 137-150
Status: Enrolling
Updated:  9/22/2015
Clinical Research Facility
mi
from
Columbus, OH
Study of the Long-Term Safety of Pramlintide in Subjects With Type 1 Diabetes Mellitus
A Multicenter, Open-Label, Extension Study of the Long-Term Safety of Pramlintide in Subjects With Type 1 Diabetes Mellitus Completing Protocol 137-150
Status: Enrolling
Updated: 9/22/2015
Clinical Research Facility
mi
from
Columbus, OH
Click here to add this to my saved trials
Study of the Long-Term Safety of Pramlintide in Subjects With Type 1 Diabetes Mellitus
A Multicenter, Open-Label, Extension Study of the Long-Term Safety of Pramlintide in Subjects With Type 1 Diabetes Mellitus Completing Protocol 137-150
Status: Enrolling
Updated:  9/22/2015
Clinical Research Facility
mi
from
Portland, OR
Study of the Long-Term Safety of Pramlintide in Subjects With Type 1 Diabetes Mellitus
A Multicenter, Open-Label, Extension Study of the Long-Term Safety of Pramlintide in Subjects With Type 1 Diabetes Mellitus Completing Protocol 137-150
Status: Enrolling
Updated: 9/22/2015
Clinical Research Facility
mi
from
Portland, OR
Click here to add this to my saved trials
Study of the Long-Term Safety of Pramlintide in Subjects With Type 1 Diabetes Mellitus
A Multicenter, Open-Label, Extension Study of the Long-Term Safety of Pramlintide in Subjects With Type 1 Diabetes Mellitus Completing Protocol 137-150
Status: Enrolling
Updated:  9/22/2015
Clinical Research Facility
mi
from
Camp Hill, PA
Study of the Long-Term Safety of Pramlintide in Subjects With Type 1 Diabetes Mellitus
A Multicenter, Open-Label, Extension Study of the Long-Term Safety of Pramlintide in Subjects With Type 1 Diabetes Mellitus Completing Protocol 137-150
Status: Enrolling
Updated: 9/22/2015
Clinical Research Facility
mi
from
Camp Hill, PA
Click here to add this to my saved trials
Study of the Long-Term Safety of Pramlintide in Subjects With Type 1 Diabetes Mellitus
A Multicenter, Open-Label, Extension Study of the Long-Term Safety of Pramlintide in Subjects With Type 1 Diabetes Mellitus Completing Protocol 137-150
Status: Enrolling
Updated:  9/22/2015
Clinical Research Facility
mi
from
Nashville, TN
Study of the Long-Term Safety of Pramlintide in Subjects With Type 1 Diabetes Mellitus
A Multicenter, Open-Label, Extension Study of the Long-Term Safety of Pramlintide in Subjects With Type 1 Diabetes Mellitus Completing Protocol 137-150
Status: Enrolling
Updated: 9/22/2015
Clinical Research Facility
mi
from
Nashville, TN
Click here to add this to my saved trials
Study of the Long-Term Safety of Pramlintide in Subjects With Type 1 Diabetes Mellitus
A Multicenter, Open-Label, Extension Study of the Long-Term Safety of Pramlintide in Subjects With Type 1 Diabetes Mellitus Completing Protocol 137-150
Status: Enrolling
Updated:  9/22/2015
Clinical Research Facility
mi
from
Irving, TX
Study of the Long-Term Safety of Pramlintide in Subjects With Type 1 Diabetes Mellitus
A Multicenter, Open-Label, Extension Study of the Long-Term Safety of Pramlintide in Subjects With Type 1 Diabetes Mellitus Completing Protocol 137-150
Status: Enrolling
Updated: 9/22/2015
Clinical Research Facility
mi
from
Irving, TX
Click here to add this to my saved trials
Study of the Long-Term Safety of Pramlintide in Subjects With Type 1 Diabetes Mellitus
A Multicenter, Open-Label, Extension Study of the Long-Term Safety of Pramlintide in Subjects With Type 1 Diabetes Mellitus Completing Protocol 137-150
Status: Enrolling
Updated:  9/22/2015
Clinical Research Facility
mi
from
San Antonio, TX
Study of the Long-Term Safety of Pramlintide in Subjects With Type 1 Diabetes Mellitus
A Multicenter, Open-Label, Extension Study of the Long-Term Safety of Pramlintide in Subjects With Type 1 Diabetes Mellitus Completing Protocol 137-150
Status: Enrolling
Updated: 9/22/2015
Clinical Research Facility
mi
from
San Antonio, TX
Click here to add this to my saved trials
Study of the Long-Term Safety of Pramlintide in Subjects With Type 1 Diabetes Mellitus
A Multicenter, Open-Label, Extension Study of the Long-Term Safety of Pramlintide in Subjects With Type 1 Diabetes Mellitus Completing Protocol 137-150
Status: Enrolling
Updated:  9/22/2015
Clinical Research Facility
mi
from
Renton, WA
Study of the Long-Term Safety of Pramlintide in Subjects With Type 1 Diabetes Mellitus
A Multicenter, Open-Label, Extension Study of the Long-Term Safety of Pramlintide in Subjects With Type 1 Diabetes Mellitus Completing Protocol 137-150
Status: Enrolling
Updated: 9/22/2015
Clinical Research Facility
mi
from
Renton, WA
Click here to add this to my saved trials
Improving Diabetes Outcomes Through Lifestyle Change (IDOLc)Study
Improving Diabetes Outcomes Through Lifestyle Change (IDOLc) Translation Study
Status: Enrolling
Updated:  9/23/2015
Diabetes Research Center - Massachusetts General Hospiral
mi
from
Boston, MA
Improving Diabetes Outcomes Through Lifestyle Change (IDOLc)Study
Improving Diabetes Outcomes Through Lifestyle Change (IDOLc) Translation Study
Status: Enrolling
Updated: 9/23/2015
Diabetes Research Center - Massachusetts General Hospiral
mi
from
Boston, MA
Click here to add this to my saved trials
Examining the Effects of Neuromodulation on Glucose Metabolism in Type 2 Diabetes
Device: Investigational Study to Examine the Effects of Neuromodulation on Glucose Metabolism in Type 2 Diabetes
Status: Enrolling
Updated:  9/23/2015
UNC Highgate Specialty Center - UNC Diabetes Care Center
mi
from
Chapel Hill, NC
Examining the Effects of Neuromodulation on Glucose Metabolism in Type 2 Diabetes
Device: Investigational Study to Examine the Effects of Neuromodulation on Glucose Metabolism in Type 2 Diabetes
Status: Enrolling
Updated: 9/23/2015
UNC Highgate Specialty Center - UNC Diabetes Care Center
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Safety and Efficacy of Dapagliflozin as Monotherapy in Subjects With Type 2 Diabetes
A Multicenter, Randomized, Double-Blind, Placebo Controlled, Parallel Group, Phase III Trial to Evaluate the Safety and Efficacy of Dapagliflozin as Monotherapy in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control With Diet and Exercise
Status: Enrolling
Updated:  9/23/2015
Dedicated Clinical Research
mi
from
Litchfield Park, AZ
Safety and Efficacy of Dapagliflozin as Monotherapy in Subjects With Type 2 Diabetes
A Multicenter, Randomized, Double-Blind, Placebo Controlled, Parallel Group, Phase III Trial to Evaluate the Safety and Efficacy of Dapagliflozin as Monotherapy in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control With Diet and Exercise
Status: Enrolling
Updated: 9/23/2015
Dedicated Clinical Research
mi
from
Litchfield Park, AZ
Click here to add this to my saved trials
Safety and Efficacy of Dapagliflozin as Monotherapy in Subjects With Type 2 Diabetes
A Multicenter, Randomized, Double-Blind, Placebo Controlled, Parallel Group, Phase III Trial to Evaluate the Safety and Efficacy of Dapagliflozin as Monotherapy in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control With Diet and Exercise
Status: Enrolling
Updated:  9/23/2015
43rd Medical Associates
mi
from
Phoenix, AZ
Safety and Efficacy of Dapagliflozin as Monotherapy in Subjects With Type 2 Diabetes
A Multicenter, Randomized, Double-Blind, Placebo Controlled, Parallel Group, Phase III Trial to Evaluate the Safety and Efficacy of Dapagliflozin as Monotherapy in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control With Diet and Exercise
Status: Enrolling
Updated: 9/23/2015
43rd Medical Associates
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Safety and Efficacy of Dapagliflozin as Monotherapy in Subjects With Type 2 Diabetes
A Multicenter, Randomized, Double-Blind, Placebo Controlled, Parallel Group, Phase III Trial to Evaluate the Safety and Efficacy of Dapagliflozin as Monotherapy in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control With Diet and Exercise
Status: Enrolling
Updated:  9/23/2015
Clinical Research Advantage, Inc.
mi
from
Tempe, AZ
Safety and Efficacy of Dapagliflozin as Monotherapy in Subjects With Type 2 Diabetes
A Multicenter, Randomized, Double-Blind, Placebo Controlled, Parallel Group, Phase III Trial to Evaluate the Safety and Efficacy of Dapagliflozin as Monotherapy in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control With Diet and Exercise
Status: Enrolling
Updated: 9/23/2015
Clinical Research Advantage, Inc.
mi
from
Tempe, AZ
Click here to add this to my saved trials
Safety and Efficacy of Dapagliflozin as Monotherapy in Subjects With Type 2 Diabetes
A Multicenter, Randomized, Double-Blind, Placebo Controlled, Parallel Group, Phase III Trial to Evaluate the Safety and Efficacy of Dapagliflozin as Monotherapy in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control With Diet and Exercise
Status: Enrolling
Updated:  9/23/2015
Valley Research
mi
from
Fresno, CA
Safety and Efficacy of Dapagliflozin as Monotherapy in Subjects With Type 2 Diabetes
A Multicenter, Randomized, Double-Blind, Placebo Controlled, Parallel Group, Phase III Trial to Evaluate the Safety and Efficacy of Dapagliflozin as Monotherapy in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control With Diet and Exercise
Status: Enrolling
Updated: 9/23/2015
Valley Research
mi
from
Fresno, CA
Click here to add this to my saved trials
Safety and Efficacy of Dapagliflozin as Monotherapy in Subjects With Type 2 Diabetes
A Multicenter, Randomized, Double-Blind, Placebo Controlled, Parallel Group, Phase III Trial to Evaluate the Safety and Efficacy of Dapagliflozin as Monotherapy in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control With Diet and Exercise
Status: Enrolling
Updated:  9/23/2015
Marina Raikhel, M.D., F.A.A.F.P
mi
from
Lomita, CA
Safety and Efficacy of Dapagliflozin as Monotherapy in Subjects With Type 2 Diabetes
A Multicenter, Randomized, Double-Blind, Placebo Controlled, Parallel Group, Phase III Trial to Evaluate the Safety and Efficacy of Dapagliflozin as Monotherapy in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control With Diet and Exercise
Status: Enrolling
Updated: 9/23/2015
Marina Raikhel, M.D., F.A.A.F.P
mi
from
Lomita, CA
Click here to add this to my saved trials
Safety and Efficacy of Dapagliflozin as Monotherapy in Subjects With Type 2 Diabetes
A Multicenter, Randomized, Double-Blind, Placebo Controlled, Parallel Group, Phase III Trial to Evaluate the Safety and Efficacy of Dapagliflozin as Monotherapy in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control With Diet and Exercise
Status: Enrolling
Updated:  9/23/2015
Richard S Cherlin
mi
from
Los Gatos, CA
Safety and Efficacy of Dapagliflozin as Monotherapy in Subjects With Type 2 Diabetes
A Multicenter, Randomized, Double-Blind, Placebo Controlled, Parallel Group, Phase III Trial to Evaluate the Safety and Efficacy of Dapagliflozin as Monotherapy in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control With Diet and Exercise
Status: Enrolling
Updated: 9/23/2015
Richard S Cherlin
mi
from
Los Gatos, CA
Click here to add this to my saved trials
Safety and Efficacy of Dapagliflozin as Monotherapy in Subjects With Type 2 Diabetes
A Multicenter, Randomized, Double-Blind, Placebo Controlled, Parallel Group, Phase III Trial to Evaluate the Safety and Efficacy of Dapagliflozin as Monotherapy in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control With Diet and Exercise
Status: Enrolling
Updated:  9/23/2015
Orange County Research Center
mi
from
Tustin, CA
Safety and Efficacy of Dapagliflozin as Monotherapy in Subjects With Type 2 Diabetes
A Multicenter, Randomized, Double-Blind, Placebo Controlled, Parallel Group, Phase III Trial to Evaluate the Safety and Efficacy of Dapagliflozin as Monotherapy in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control With Diet and Exercise
Status: Enrolling
Updated: 9/23/2015
Orange County Research Center
mi
from
Tustin, CA
Click here to add this to my saved trials
Safety and Efficacy of Dapagliflozin as Monotherapy in Subjects With Type 2 Diabetes
A Multicenter, Randomized, Double-Blind, Placebo Controlled, Parallel Group, Phase III Trial to Evaluate the Safety and Efficacy of Dapagliflozin as Monotherapy in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control With Diet and Exercise
Status: Enrolling
Updated:  9/23/2015
Family Physicians Of Greeley
mi
from
Greeley, CO
Safety and Efficacy of Dapagliflozin as Monotherapy in Subjects With Type 2 Diabetes
A Multicenter, Randomized, Double-Blind, Placebo Controlled, Parallel Group, Phase III Trial to Evaluate the Safety and Efficacy of Dapagliflozin as Monotherapy in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control With Diet and Exercise
Status: Enrolling
Updated: 9/23/2015
Family Physicians Of Greeley
mi
from
Greeley, CO
Click here to add this to my saved trials
Safety and Efficacy of Dapagliflozin as Monotherapy in Subjects With Type 2 Diabetes
A Multicenter, Randomized, Double-Blind, Placebo Controlled, Parallel Group, Phase III Trial to Evaluate the Safety and Efficacy of Dapagliflozin as Monotherapy in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control With Diet and Exercise
Status: Enrolling
Updated:  9/23/2015
Coastal Connecticut Research, LLC
mi
from
New London, CT
Safety and Efficacy of Dapagliflozin as Monotherapy in Subjects With Type 2 Diabetes
A Multicenter, Randomized, Double-Blind, Placebo Controlled, Parallel Group, Phase III Trial to Evaluate the Safety and Efficacy of Dapagliflozin as Monotherapy in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control With Diet and Exercise
Status: Enrolling
Updated: 9/23/2015
Coastal Connecticut Research, LLC
mi
from
New London, CT
Click here to add this to my saved trials
Safety and Efficacy of Dapagliflozin as Monotherapy in Subjects With Type 2 Diabetes
A Multicenter, Randomized, Double-Blind, Placebo Controlled, Parallel Group, Phase III Trial to Evaluate the Safety and Efficacy of Dapagliflozin as Monotherapy in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control With Diet and Exercise
Status: Enrolling
Updated:  9/23/2015
Central Florida Clinical Trials
mi
from
Altamonte Springs, FL
Safety and Efficacy of Dapagliflozin as Monotherapy in Subjects With Type 2 Diabetes
A Multicenter, Randomized, Double-Blind, Placebo Controlled, Parallel Group, Phase III Trial to Evaluate the Safety and Efficacy of Dapagliflozin as Monotherapy in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control With Diet and Exercise
Status: Enrolling
Updated: 9/23/2015
Central Florida Clinical Trials
mi
from
Altamonte Springs, FL
Click here to add this to my saved trials
Safety and Efficacy of Dapagliflozin as Monotherapy in Subjects With Type 2 Diabetes
A Multicenter, Randomized, Double-Blind, Placebo Controlled, Parallel Group, Phase III Trial to Evaluate the Safety and Efficacy of Dapagliflozin as Monotherapy in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control With Diet and Exercise
Status: Enrolling
Updated:  9/23/2015
Westside Center for Clinical Research
mi
from
Jacksonville, FL
Safety and Efficacy of Dapagliflozin as Monotherapy in Subjects With Type 2 Diabetes
A Multicenter, Randomized, Double-Blind, Placebo Controlled, Parallel Group, Phase III Trial to Evaluate the Safety and Efficacy of Dapagliflozin as Monotherapy in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control With Diet and Exercise
Status: Enrolling
Updated: 9/23/2015
Westside Center for Clinical Research
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Safety and Efficacy of Dapagliflozin as Monotherapy in Subjects With Type 2 Diabetes
A Multicenter, Randomized, Double-Blind, Placebo Controlled, Parallel Group, Phase III Trial to Evaluate the Safety and Efficacy of Dapagliflozin as Monotherapy in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control With Diet and Exercise
Status: Enrolling
Updated:  9/23/2015
Panhandle Family Care Associates
mi
from
Marianna, FL
Safety and Efficacy of Dapagliflozin as Monotherapy in Subjects With Type 2 Diabetes
A Multicenter, Randomized, Double-Blind, Placebo Controlled, Parallel Group, Phase III Trial to Evaluate the Safety and Efficacy of Dapagliflozin as Monotherapy in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control With Diet and Exercise
Status: Enrolling
Updated: 9/23/2015
Panhandle Family Care Associates
mi
from
Marianna, FL
Click here to add this to my saved trials
Safety and Efficacy of Dapagliflozin as Monotherapy in Subjects With Type 2 Diabetes
A Multicenter, Randomized, Double-Blind, Placebo Controlled, Parallel Group, Phase III Trial to Evaluate the Safety and Efficacy of Dapagliflozin as Monotherapy in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control With Diet and Exercise
Status: Enrolling
Updated:  9/23/2015
Endocrine Research Solutions, Inc.
mi
from
Roswell, GA
Safety and Efficacy of Dapagliflozin as Monotherapy in Subjects With Type 2 Diabetes
A Multicenter, Randomized, Double-Blind, Placebo Controlled, Parallel Group, Phase III Trial to Evaluate the Safety and Efficacy of Dapagliflozin as Monotherapy in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control With Diet and Exercise
Status: Enrolling
Updated: 9/23/2015
Endocrine Research Solutions, Inc.
mi
from
Roswell, GA
Click here to add this to my saved trials
Safety and Efficacy of Dapagliflozin as Monotherapy in Subjects With Type 2 Diabetes
A Multicenter, Randomized, Double-Blind, Placebo Controlled, Parallel Group, Phase III Trial to Evaluate the Safety and Efficacy of Dapagliflozin as Monotherapy in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control With Diet and Exercise
Status: Enrolling
Updated:  9/23/2015
Belzoni Clinical Research
mi
from
Belzoni, MS
Safety and Efficacy of Dapagliflozin as Monotherapy in Subjects With Type 2 Diabetes
A Multicenter, Randomized, Double-Blind, Placebo Controlled, Parallel Group, Phase III Trial to Evaluate the Safety and Efficacy of Dapagliflozin as Monotherapy in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control With Diet and Exercise
Status: Enrolling
Updated: 9/23/2015
Belzoni Clinical Research
mi
from
Belzoni, MS
Click here to add this to my saved trials
Safety and Efficacy of Dapagliflozin as Monotherapy in Subjects With Type 2 Diabetes
A Multicenter, Randomized, Double-Blind, Placebo Controlled, Parallel Group, Phase III Trial to Evaluate the Safety and Efficacy of Dapagliflozin as Monotherapy in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control With Diet and Exercise
Status: Enrolling
Updated:  9/23/2015
R-Research
mi
from
Hamilton, NJ
Safety and Efficacy of Dapagliflozin as Monotherapy in Subjects With Type 2 Diabetes
A Multicenter, Randomized, Double-Blind, Placebo Controlled, Parallel Group, Phase III Trial to Evaluate the Safety and Efficacy of Dapagliflozin as Monotherapy in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control With Diet and Exercise
Status: Enrolling
Updated: 9/23/2015
R-Research
mi
from
Hamilton, NJ
Click here to add this to my saved trials
Safety and Efficacy of Dapagliflozin as Monotherapy in Subjects With Type 2 Diabetes
A Multicenter, Randomized, Double-Blind, Placebo Controlled, Parallel Group, Phase III Trial to Evaluate the Safety and Efficacy of Dapagliflozin as Monotherapy in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control With Diet and Exercise
Status: Enrolling
Updated:  9/23/2015
Internist Associates Of Central New York
mi
from
Syracuse, NY
Safety and Efficacy of Dapagliflozin as Monotherapy in Subjects With Type 2 Diabetes
A Multicenter, Randomized, Double-Blind, Placebo Controlled, Parallel Group, Phase III Trial to Evaluate the Safety and Efficacy of Dapagliflozin as Monotherapy in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control With Diet and Exercise
Status: Enrolling
Updated: 9/23/2015
Internist Associates Of Central New York
mi
from
Syracuse, NY
Click here to add this to my saved trials
Safety and Efficacy of Dapagliflozin as Monotherapy in Subjects With Type 2 Diabetes
A Multicenter, Randomized, Double-Blind, Placebo Controlled, Parallel Group, Phase III Trial to Evaluate the Safety and Efficacy of Dapagliflozin as Monotherapy in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control With Diet and Exercise
Status: Enrolling
Updated:  9/23/2015
Southgate Medical Group
mi
from
West Seneca, NY
Safety and Efficacy of Dapagliflozin as Monotherapy in Subjects With Type 2 Diabetes
A Multicenter, Randomized, Double-Blind, Placebo Controlled, Parallel Group, Phase III Trial to Evaluate the Safety and Efficacy of Dapagliflozin as Monotherapy in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control With Diet and Exercise
Status: Enrolling
Updated: 9/23/2015
Southgate Medical Group
mi
from
West Seneca, NY
Click here to add this to my saved trials
Safety and Efficacy of Dapagliflozin as Monotherapy in Subjects With Type 2 Diabetes
A Multicenter, Randomized, Double-Blind, Placebo Controlled, Parallel Group, Phase III Trial to Evaluate the Safety and Efficacy of Dapagliflozin as Monotherapy in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control With Diet and Exercise
Status: Enrolling
Updated:  9/23/2015
Down East Medical Associates
mi
from
Morehead City, NC
Safety and Efficacy of Dapagliflozin as Monotherapy in Subjects With Type 2 Diabetes
A Multicenter, Randomized, Double-Blind, Placebo Controlled, Parallel Group, Phase III Trial to Evaluate the Safety and Efficacy of Dapagliflozin as Monotherapy in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control With Diet and Exercise
Status: Enrolling
Updated: 9/23/2015
Down East Medical Associates
mi
from
Morehead City, NC
Click here to add this to my saved trials
Safety and Efficacy of Dapagliflozin as Monotherapy in Subjects With Type 2 Diabetes
A Multicenter, Randomized, Double-Blind, Placebo Controlled, Parallel Group, Phase III Trial to Evaluate the Safety and Efficacy of Dapagliflozin as Monotherapy in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control With Diet and Exercise
Status: Enrolling
Updated:  9/23/2015
James J. Brown, Md
mi
from
Akron, OH
Safety and Efficacy of Dapagliflozin as Monotherapy in Subjects With Type 2 Diabetes
A Multicenter, Randomized, Double-Blind, Placebo Controlled, Parallel Group, Phase III Trial to Evaluate the Safety and Efficacy of Dapagliflozin as Monotherapy in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control With Diet and Exercise
Status: Enrolling
Updated: 9/23/2015
James J. Brown, Md
mi
from
Akron, OH
Click here to add this to my saved trials